CVE-2025-41257

CVE-2025-41257 is a medium-severity vulnerability with a CVSS 3.x base score of 4.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-20.

Key facts

Description

Suprema’s BioStar 2 in version 2.9.11.6 allows users to set new password without providing the current one. Exploiting this flaw combined with other vulnerabilities can lead to unauthorized account access and potential system compromise.

Frequently asked questions

What is CVE-2025-41257?
Suprema’s BioStar 2 in version 2.9.11.6 allows users to set new password without providing the current one. Exploiting this flaw combined with other vulnerabilities can lead to unauthorized account access and potential system compromise.
How severe is CVE-2025-41257?
CVE-2025-41257 has a CVSS 3.x base score of 4.8, rated medium severity. It is exploitable over network with high attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2025-41257 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (16th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2025-41257?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-41257 have an EU (EUVD) identifier?
Yes. CVE-2025-41257 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-208295.
When was CVE-2025-41257 published?
CVE-2025-41257 was published on 2026-03-04 and last updated on 2026-06-17.

References

Other CWE-20 (Improper Input Validation) vulnerabilities

Browse all CWE-20 (Improper Input Validation) vulnerabilities →